---
title: Fresh Corneal Lenticule Implantation and Autologous Serum - Case Report
nct_id: NCT04594512
overall_status: ACTIVE_NOT_RECRUITING
phase: NA
sponsor: Eye Hospital Pristina Kosovo
study_type: INTERVENTIONAL
primary_condition: Keratoconus
countries: Kosovo
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT04594512.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT04594512"
ct_last_update_post_date: 2024-08-27
last_seen_at: "2026-05-12T07:16:10.885Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Fresh Corneal Lenticule Implantation and Autologous Serum - Case Report

**Official Title:** Fresh Corneal Lenticule Implantation and Autologous Serum - New Approach in Treatment of Advanced Keratoconus Disease - Case Report

**NCT ID:** [NCT04594512](https://clinicaltrials.gov/study/NCT04594512)

## Key Facts

- **Status:** ACTIVE_NOT_RECRUITING
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 1
- **Lead Sponsor:** Eye Hospital Pristina Kosovo
- **Conditions:** Keratoconus, Keratoconus of Right Eye, Keratoconus, Unstable, Right Eye
- **Start Date:** 2019-05-08
- **Completion Date:** 2026-05-08
- **CT.gov Last Update:** 2024-08-27

## Brief Summary

The aim of our study is to investigate the feasibility and the effect of fresh lenticule implantation as allogenic graft that will be taken from myopic patients to implant in patients with keratoconus disease using VisuMax Femtosescond laser- Smile module surgery with primary objective to increase central corneal thickness and secondary to improve visual acuity and reduces K-values and to show the autologous serum drop improve the recovery of patients with mild dry eye in keratoconus disease.

## Detailed Description

A 19-year-old female patient with keratoconus and chronic hydrops cornea referred to the cornea department of our clinic with thin cornea and hydrops in chronic stage and minimal dry eye symptoms. Minimum corneal pachymetry in the right eye was 378 µm as measured by optical coherence tomography(AS-OCT-Zeiss). Atlas corneal topography showed steep K-values 82.60 ax.37 and flat K 75.15 D ax 127 with -7.45 corneal astigmatism. Her best corrected visual acuity was 0.0.5 in right eye and 1.0 in the left eye. Slit lamp examination showed intense punctate epitheliopathy (Figure 1), tear film break-up time (TBUT) was measured as 7-8 sec and Schirmer test was 10 mm in right eye, and the other eye examinations were determined normally.

## Eligibility

- **Minimum age:** 19 Years
- **Maximum age:** 20 Years
- **Sex:** FEMALE
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Be at least 18 years of age, male or female, of any race
* Willingness and ability to follow all instructions and comply with schedule for follow-up visits
* For females: Must not be pregnant

Exclusion Criteria:

* Contraindications, sensitivity or known allergy to the use of the test article(s) or their components
* If female, pregnant
```

## Arms

- **LENTICULE IMPLANTATION** (OTHER) — The present study may suggest that this procedure safely, reliably, and effectively increases corneal thickness and improves visual acuity with no adverse effects. It may even provide new avenues in the treatment of corneal ectasia. Stem cells and live keratocytes are well organized based on cornea transparency and in anterior segment OCT.

## Interventions

- **Fresh corneal lenticule and autologous serum in advanced keratoconus using ReLex Smile surgery** (OTHER) — A 19-year-old female patient with keratoconus and chronic hydrops cornea referred to the cornea department of our clinic with thin cornea and hydrops in chronic stage and minimal dry eye symptoms. Minimum corneal pachymetry in the right eye was 378 µm as measured by optical coherence tomography(AS-OCT-Zeiss). Atlas corneal topography showed steep K-values 82.60 ax.37 and flat K 75.15 D ax 127 with -7.45 corneal astigmatism. Her best corrected visual acuity was 0.0.5 in right eye and 1.0 in the left eye. Slit lamp examination showed intense punctate epitheliopathy (Figure 1), tear film break-up time (TBUT) was measured as 7-8 sec and Schirmer test was 10 mm in right eye, and the other eye examinations were determined normally

## Primary Outcomes

- **Treatment of advanced keratoconus disease** _(time frame: 12 months)_ — Change of corneal central thickness using fresh lenticule with stromal stem cells, live keratocites and autologous serum

## Locations (1)

- Eye Hospital Pristina, Pristina, Kosovo

## Recent Field Changes (last 30 days)

- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.eye hospital pristina|pristina||kosovo` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT04594512.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT04594512*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*